RecruitingNot ApplicableNCT05633628

Periodic Continuous Glucose Monitoring in Patients With Type 2 Diabetes

Periodic Continuous Glucose Monitoring to Support a Person-centered Approach During Diabetes Consultations in Patients With Type 2 Diabetes- A Randomised Controlled Study

Sponsor

Sophiahemmet University

Enrollment

400 participants

Start Date

Feb 1, 2023

Study Type

INTERVENTIONAL

Conditions

Type 2 Diabetes

Summary

The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether using a continuous glucose monitor (CGM) — a small wearable sensor that tracks blood sugar around the clock — periodically (rather than all the time) can help people with type 2 diabetes manage their blood sugar better compared to standard finger-prick testing. **You may be eligible if...** - You are between 18 and 80 years old - You have had type 2 diabetes for more than 6 months - Your HbA1c (a 3-month average blood sugar measure) is in a specific moderate range - You own a smartphone and have experience testing your blood sugar at home **You may NOT be eligible if...** - You currently take insulin with meals - You are pregnant or planning to become pregnant - Your blood sugar is either very well controlled or very poorly controlled Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPeriodic CGM group with data analysis report- Intervention group

The patients are also instructed to continue to perform SMBG by finger prick if they experience symptoms of hypo- or hyperglycemia. During visit 0 (baseline) the patients is also instructed about how they can log in to the National Diabetes Register (NDR) to access their own NDR's recorded data and use the diabetes questionnaire.